The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.
Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Hyperglycemic Pseudohypoxia and Diabetic Complications
Williamson, J. R., Chang, K., Frangos, M., Hasan, K. S., Ido, Y., Kawamura, T., Nyengaard, J. R., Den Enden, M. V., Kilo, C., & Tilton, R. G. (1993) · Diabetes · doi:10.2337/diab.42.6.801 · Cited by 1,105
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912
Du, X., Matsumura, T., Edelstein, D., Rossetti, L., Zsengellér, Z., Szabó, C., & Brownlee, M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18127 · Cited by 832
Myocardial Cell Death in Human Diabetes
Frustaci, A., Kajstura, J., Chimenti, C., Jakoniuk, I., Leri, A., Maseri, A., Nadal-Ginard, B., & Anversa, P. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1123 · Cited by 796
The Sorbitol Pathway and the Complications of Diabetes
Steinmetz, P. R., Balko, C., & Gabbay, K. H. (1973) · New England Journal of Medicine · doi:10.1056/nejm197304192881609 · Cited by 759
Inoguchi, T., Battan, R., Handler, E., Sportsman, J. R., Heath, W., & King, G. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.11059 · Cited by 740
The Role of Inflammatory Cytokines in Diabetes and Its Complications
King, G. L. (2008) · Journal of Periodontology · doi:10.1902/jop.2008.080246 · Cited by 679
Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
Elmarakby, A. A., & Sullivan, J. C. (2012) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2010.00218.x · Cited by 641
Kuboki, K., Jiang, Z. Y., Takahara, N., Ha, S. W., Igarashi, M., Yamauchi, T., Feener, E. P., Herbert, T. P., Rhodes, C. J., & King, G. L. (2000) · Circulation · doi:10.1161/01.cir.101.6.676 · Cited by 639
Glycation and Diabetic Complications
Brownlee, M. (1994) · Diabetes · doi:10.2337/diab.43.6.836 · Cited by 632
NADPH Oxidases in Cardiovascular Health and Disease
Cave, A. C., Brewer, A. C., Narayanapanicker, A., Ray, R., Grieve, D. J., Walker, S., & Shah, A. M. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.691 · Cited by 630
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Kanwar, Y. S., Wada, J., Sun, L., Xie, P., Wallner, E. I., Chen, S., Chugh, S., & Danesh, F. R. (2008) · Experimental Biology and Medicine · doi:10.3181/0705-mr-134 · Cited by 596
Chow, F., Ozols, E., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00367.x · Cited by 551
Mechanisms of Vascular Aging: New Perspectives
Ungvari, Z., Kaley, G., de Cabo, R., Sonntag, W. E., & Csiszar, A. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq113 · Cited by 531
Redox signaling in angiogenesis: Role of NADPH oxidase
USHIOFUKAI, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.04.015 · Cited by 490
Diabetic Cardiomyopathy: Insights into Pathogenesis, Diagnostic Challenges, and Therapeutic Options
Aneja, A., Tang, W. H. W., Bansilal, S., Garcia, M. J., & Farkouh, M. E. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.03.046 · Cited by 482
Monnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
Morigi, M., Angioletti, S., Imberti, B., Donadelli, R., Micheletti, G., Figliuzzi, M., Remuzzi, A., Zoja, C., & Remuzzi, G. (1998) · Journal of Clinical Investigation · doi:10.1172/jci656 · Cited by 438
Inoguchi, T., Sonta, T., Tsubouchi, H., Etoh, T., Kakimoto, M., Sonoda, N., Sato, N., Sekiguchi, N., Kobayashi, K., Sumimoto, H., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077407.90309.65 · Cited by 435
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Advanced Glycation end Products, Oxidative Stress and Diabetic Nephropathy
Yamagishi, S.-I., & Matsui, T. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.2.11148 · Cited by 397
Progression of diabetic nephropathy
Hovind, P., Rossing, P., Tarnow, L., Smidt, U. M., & Parving, H.-H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.059002702.x · Cited by 383
Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
Galkina, E., & Ley, K. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080859 · Cited by 376
Wolf, G. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01429.x · Cited by 360
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
HAYAT, S. A., PATEL, B., KHATTAR, R. S., & MALIK, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 352
Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis.
Benjamin, I. J., Jalil, J. E., Tan, L. B., Cho, K., Weber, K. T., & Clark, W. A. (1989) · Circulation Research · doi:10.1161/01.res.65.3.657 · Cited by 343
Du, Y., Veenstra, A., Palczewski, K., & Kern, T. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314575110 · Cited by 335
Macrophage accumulation in human progressive diabetic nephropathy
NGUYEN, D., PING, F., MU, W., HILL, P., ATKINS, R. C., & CHADBAN, S. J. (2006) · Nephrology · doi:10.1111/j.1440-1797.2006.00576.x · Cited by 331
Mizushige, K., Yao, L., Noma, T., Kiyomoto, H., Yu, Y., Hosomi, N., Ohmori, K., & Matsuo, H. (2000) · Circulation · doi:10.1161/01.cir.101.8.899 · Cited by 326
Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Dalla Vestra, M., Mussap, M., Gallina, P., Bruseghin, M., Cernigoi, A. M., Saller, A., Plebani, M., & Fioretto, P. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004110961 · Cited by 303
Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes
Pieper, A. A., Brat, D. J., Krug, D. K., Watkins, C. C., Gupta, A., Blackshaw, S., Verma, A., Wang, Z.-Q., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3059 · Cited by 298
Yamagishi, S.-I., Maeda, S., Matsui, T., Ueda, S., Fukami, K., & Okuda, S. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.014 · Cited by 294
Glycation Induces Formation of Amyloid Cross-β Structure in Albumin
Bouma, B., Kroon-Batenburg, L. M. J., Wu, Y.-P., Brünjes, B., Posthuma, G., Kranenburg, O., de Groot, P. G., Voest, E. E., & Gebbink, M. F. B. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303925200 · Cited by 286
Ha, H., Yu, M. R., Choi, Y. J., Kitamura, M., & Lee, H. B. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v134894 · Cited by 273
Szczepaniak, L. S., Victor, R. G., Orci, L., & Unger, R. H. (2007) · Circulation Research · doi:10.1161/circresaha.107.160457 · Cited by 257
Knouff, C., & Auwerx, J. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0036 · Cited by 256
SUZUKI, D., MIYATA, T., SAOTOME, N., HORIE, K., INAGI, R., YASUDA, Y., UCHIDA, K., IZUHARA, Y., YAGAME, M., SAKAI, H., et al. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v104822 · Cited by 254
AGEs, RAGE, and Diabetic Retinopathy
Zong, H., Ward, M., & Stitt, A. W. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0198-7 · Cited by 252
Metabolic disturbances in diabetic cardiomyopathy.
Rodrigues, B. B., Cam, M. C., & McNeill, J. H. (1998) · PubMed · Cited by 248
McCarthy, E. T., Sharma, R., Sharma, M., Li, J. Z., Ge, X. L., Dileepan, K. N., & Savin, V. J. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v93433 · Cited by 231
Diabetic nephropathy: Prevention and treatment
Parving, H.-H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00020.x · Cited by 226
Cameron, N. E., & Cotter, M. A. (1992) · Diabetologia · doi:10.1007/bf02221675 · Cited by 212
Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis
Chow, F. Y., Nikolic-Paterson, D. J., Atkins, R. C., & Tesch, G. H. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh441 · Cited by 206
Packham, D. K., Alves, T. P., Dwyer, J. P., Atkins, R., de Zeeuw, D., Cooper, M., Shahinfar, S., Lewis, J. B., & Lambers Heerspink, H. J. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.09.017 · Cited by 205
Ohga, S., Shikata, K., Yozai, K., Okada, S., Ogawa, D., Usui, H., Wada, J., Shikata, Y., & Makino, H. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00288.2005 · Cited by 203
Sano, T., Umeda, F., Hashimoto, T., Nawata, H., & Utsumi, H. (1998) · Diabetologia · doi:10.1007/s001250051076 · Cited by 195
Pathogenic perspectives for the role of inflammation in diabetic nephropathy
Rivero, A., Mora, C., Muros, M., García, J., Herrera, H., & Navarro-González, J. F. (2009) · Clinical Science · doi:10.1042/cs20080394 · Cited by 190
Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
Mott, J. D., Khalifah, R. G., Nagase, H., Shield, C. F., Hudson, J. K., & Hudson, B. G. (1997) · Kidney International · doi:10.1038/ki.1997.455 · Cited by 170
Palmitate-mediated Alterations in the Fatty Acid Metabolism of Rat Neonatal Cardiac Myocytes
Hickson-Bick, D. L. M., Buja, M. L., & McMillin, J. B. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1098 · Cited by 170
Zieman, S. J., & Kass, D. A. (2004) · Drugs · doi:10.2165/00003495-200464050-00001 · Cited by 166
Wu, Y. H., Tang, L., & Chen, B. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/752387 · Cited by 152
Harte, A. L., McTernan, P. G., Chetty, R., Coppack, S. W., Katz, J. R., Smith, S., & Kumar, S. (2005) · Circulation · doi:10.1161/01.cir.0000161954.17870.5d · Cited by 149
Diabetes-induced Myocardial Structural Changes: Role of Endothelin-1 and its Receptors
Chen, S., Evans, T., Mukherjee, K., Karmazyn, M., & Chakrabarti, S. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1197 · Cited by 141
Role of nitric oxide, superoxide, peroxynitrite and PARP in diabetic retinopathy
Zheng, L., & Kern, T. S. (2009) · Frontiers in bioscience · doi:10.2741/3505 · Cited by 139
Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats
Abe, T., Ohga, Y., Tabayashi, N., Kobayashi, S., Sakata, S., Misawa, H., Tsuji, T., Kohzuki, H., Suga, H., Taniguchi, S., et al. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2002.282.1.h138 · Cited by 136
Kim, S., & Ha, J. (2009) · Korean Diabetes Journal · doi:10.4093/kdj.2009.33.1.9 · Cited by 134
Leal, E. C., Martins, J., Voabil, P., Liberal, J. M. T., Chiavaroli, C., Bauer, J., Cunha-Vaz, J. G., & Ambrósio, A. F. (2010) · Diabetes · doi:10.2337/db09-1421 · Cited by 132
Expression and Function of Peroxisome Proliferator–Activated Receptor-γ in Mesangial Cells
Nicholas, S. B., Kawano, Y., Wakino, S., Collins, A. R., & Hsueh, W. A. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.722 · Cited by 132
Protein kinase C activation and its pharmacological inhibition in vascular disease
Meier, M., & King, G. L. (2000) · Vascular Medicine · doi:10.1177/1358836x0000500307 · Cited by 130
Thioredoxin Interacting Protein (TXNIP) and Pathogenesis of Diabetic Retinopathy
Singh, L. P. (2013) · Journal of Clinical & Experimental Ophthalmology · doi:10.4172/2155-9570.1000287 · Cited by 122
Li, Y., Wen, X., Spataro, B. C., Hu, K., Dai, C., & Liu, Y. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030257 · Cited by 119
Self-citationPioglitazone Inhibits Cell Growth and Reduces Matrix Production in Human Kidney Fibroblasts
Zafiriou, S., Stanners, S. R., Saad, S., Polhill, T. S., Poronnik, P., & Pollock, C. A. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004040278 · Cited by 111
Advanced glycation end products and diabetic retinopathy
Milne, R. W., & Brownstein, S. (2011) · Amino Acids · doi:10.1007/s00726-011-1071-3 · Cited by 105
Aldose Reductase / Polyol Inhibitors for Diabetic Retinopathy
Obrosova, I. G., & Kador, P. F. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111794480642 · Cited by 102
Oxidative stress in diabetic nephropathy: Basic and clinical information
Ha, H., & Lee, H. B. (2001) · Current Diabetes Reports · doi:10.1007/s11892-001-0047-1 · Cited by 101
Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E
Ganz, M. B., & Seftel, A. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.1.e146 · Cited by 101
Inflammation and Pharmacological Treatment in Diabetic Retinopathy
Kaštelan, S., Tomić, M., Antunica, A. G., Rabatić, J. S., & Ljubić, S. (2013) · Mediators of Inflammation · doi:10.1155/2013/213130 · Cited by 100
Heart Failure and Diabetes Mellitus: Epidemiology and Management of an Alarming Association
Solal, A. C., Beauvais, F., & Logeart, D. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.04.001 · Cited by 99
Brown, W. V. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.068 · Cited by 90
Yang, Z., Zingarelli, B., & Szabó, C. (2000) · Shock · doi:10.1097/00024382-200013010-00011 · Cited by 89
Galler, A., Müller, G., Schinzel, R., Kratzsch, J., Kieß, W., & Münch, G. W. (2003) · Diabetes Care · doi:10.2337/diacare.26.9.2609 · Cited by 82
Diabetic cardiomyopathy – a distinct disease?
Khavandi, K., Khavandi, A., Asghar, O., Greenstein, A. S., Withers, S., Heagerty, A. M., & Malik, R. A. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.10.016 · Cited by 81
Wu, J. C., Mei, C., Vlassara, H., Striker, G. E., & Zheng, F. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00078.2009 · Cited by 79
Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy.
Wilson, J. M., Villareal, R. P., Hariharan, R., Massumi, A., Muthupillai, R., & Flamm, S. D. (2002) · PubMed · Cited by 78
Gürel, Z., Zaro, B. W., Pratt, M. R., & Sheibani, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095561 · Cited by 74
Advanced glycation end products and diabetic retinopathy
Sharma, Y., Saxena, S., Mishra, A., Saxena, A., & Natu, S. M. (2012) · Journal of ocular biology, diseases, and informatics · doi:10.1007/s12177-013-9104-7 · Cited by 73
PARP mediates structural alterations in diabetic cardiomyopathy
Chiu, J., Farhangkhoee, H., Xu, B. Y., Chen, S., George, B., & Chakrabarti, S. (2008) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.06.009 · Cited by 70
Kim, D., Park, M.-J., Lim, S.-K., Choi, J., Kim, J.-C., Han, H. J., Kundu, T. K., Park, J.-I., Yoon, K. C., Park, S., et al. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.07.021 · Cited by 69
Sabatino, L., Casamassimi, A., Peluso, G., Barone, M. V., Capaccio, D., Migliore, C., Bonelli, P., Pedicini, A., Febbraro, A., Ciccodicola, A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502716200 · Cited by 68
Role of PPARγ in renoprotection in Type 2 diabetes: molecular mechanisms and therapeutic potential
Yang, J., Zhang, D., Li, J., Zhang, X., Fan, F., & Guan, Y. (2008) · Clinical Science · doi:10.1042/cs20070462 · Cited by 67
Yamagishi, S., Matsui, T., Nakamura, K., Inoue, H., Takeuchi, M., Ueda, S., Okuda, S., & Imaizumi, T. (2007) · Ophthalmic Research · doi:10.1159/000111152 · Cited by 60
Diabetic Cardiomyopathy and Carnitine Deficiency
Malone, J. I., Schocken, D. D., Morrison, A. D., & Gilbert‐Barness, E. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(99)00039-2 · Cited by 56
Redox regulation of Ito remodeling in diabetic rat heart
Li, X., Zhi, X., Li, S., & Rozanski, G. J. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00559.2004 · Cited by 54
Self-citationPARP as a drug target for the therapy of diabetic cardiovascular dysfunction
Szabó, C. (2002) · Drug News & Perspectives · doi:10.1358/dnp.2002.15.4.840052 · Cited by 53
Elmarakby, A. A., Abdelsayed, R. A., Liu, J. Y., & Mozaffari, M. S. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0004-7 · Cited by 48
MAEDA, A., Horikoshi, S., Gohda, T., TSUGE, T., Maeda, K., & Tomino, Y. (2005) · Cell Biology International · doi:10.1016/j.cellbi.2005.01.005 · Cited by 46
Sušić, D., Varagić, J., Ahn, J., & Frohlich, E. D. (2004) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/1568006043481347 · Cited by 45
Yung, S., Chau, M. K. M., Zhang, Q., Zhang, C. Z., & Chan, T. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054501 · Cited by 42
Suganuma, E., Babaev, V. R., Motojima, M., Zuo, Y., Ayabe, N., Fogo, A. B., Ichikawa, I., Linton, M. F., Fazio, S., & Kon, V. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006090967 · Cited by 39
Sugawara, A., Takeuchi, K., Uruno, A., Ikeda, Y., Arima, S., Sato, K., Kudo, M., Taniyama, Y., & Ito, S. (2001) · Hypertension Research · doi:10.1291/hypres.24.229 · Cited by 38
Zhang, L., Xia, H., Han, Q., & Chen, B. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2827-8 · Cited by 34
Evidence‐Based Hypertension Treatment in Patients With Diabetes
Garcia‐Touza, M., & Sowers, J. R. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00570.x · Cited by 33
Simó, R., & Hernández, C. (2012) · Reviews on Recent Clinical Trials · doi:10.2174/157488712799363299 · Cited by 32
Erianin induces a JNK/SAPK-dependent metabolic inhibition in human umbilical vein endothelial cells.
Gong, Y., Fan, Y., Liu, L., Wu, D., Chang, Z., & Wang, Z. (2004) · PubMed · Cited by 32
Malecki, M. T., Cyganek, K., Mirkiewicz-Sieradzka, B., Wołkow, P. P., Wanic, K., SKUPIEN, J. K., Solnica, B., & Sieradzki, J. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.11.001 · Cited by 31
PPARγ and chronic kidney disease
Fogo, A. B. (2010) · Pediatric Nephrology · doi:10.1007/s00467-010-1602-2 · Cited by 29
Radical approach to diabetic nephropathy
Lee, H. B., Seo, J. Y., Yu, M. R., Uh, S., & Ha, H. (2007) · Kidney International · doi:10.1038/sj.ki.5002389 · Cited by 27
Nakayama, H., Morozumi, T., Nanto, S., Shimonagata, T., Ohara, T., 鷹野, 譲., Kotani, J., Watanabe, T., Fujita, M., Nishio, M., et al. (2001) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.65.783 · Cited by 26
Predictors of diabetic cardiomyopathy in asymptomatic patients with type 2 diabetes
Seferovi, J., Seferovi, P. M., Bosiljka, T. V., Petrovi, M., Ristić, A. D., Lalic, K. S., Jotić, A., Tesic, M. B., Giga, V. L., Mili, N. Y., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.052 · Cited by 20
Cao, Z., & Cooper, M. E. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0328-3 · Cited by 20
Cited by
Giri, B., Dey, S., Das, T., Sarkar, M., Banerjee, J., & Dash, S. K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.157 · Cited by 635
Nagaishi, K., Mizue, Y., Chikenji, T., Otani, M., Nakano, M., Konari, N., & Fujimiya, M. (2016) · Scientific Reports · doi:10.1038/srep34842 · Cited by 257
Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy
Xu, J., Chen, L.-J., Yu, J., Wang, H.-J., Zhang, F., Liu, Q., & Wu, J. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000491897 · Cited by 204
Role of p53/miR-155-5p/sirt1 loop in renal tubular injury of diabetic kidney disease
Wang, Y., Zheng, Z.-J., Jia, Y.-J., Yang, Y.-L., & Xue, Y.-M. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1486-7 · Cited by 115
Thymoquinone and diallyl sulfide protect against fipronil-induced oxidative injury in rats
Abdel-Daim, M. M., Shaheen, H. M., Abushouk, A. I., Toraih, E. A., Fawzy, M. S., Alansari, W. S., Aleya, L., & Bungau, S. (2018) · Environmental Science and Pollution Research · doi:10.1007/s11356-018-2386-3 · Cited by 65
Metadata
- Authors
- Wan, T.-T., Li, X.-F., Sun, Y.-M., Li, Y.-B., & Su, Y.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 74
- Pages
- 145-147
- ISSN
- 0753-3322 (ISSN-L)
- OpenAlex
- W2069686033
- Cited by
- 291
- References
- 104
- FWCI
- 33.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.